{"id":"W1991823030","doi":"10.1007/s10637-007-9066-3","title":"A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium","year":2007,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Pancreatic carcinoma; Medicine; Internal medicine; Phases of clinical research; Oncology; Deoxycytidine; Chemotherapy; Pancreatic cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001890639,0.001634908,0.001768524,0.0005353982,0.0004560846,0.0009299612,0.001199874,0.001758446,0.00411834],"category_scores_gemma":[0.001140954,0.000696165,0.001441807,0.0005692803,0.001081636,0.0008720314,0.0004242662,0.003955918,0.0007965231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000875675,"about_ca_system_score_gemma":0.001422163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001739647,"about_ca_topic_score_gemma":0.003355467,"domain_scores_codex":[0.9995353,0.0002690675,0.00001576798,0.00005792671,0.00003340276,0.00008864346],"domain_scores_gemma":[0.9988808,0.0002499654,0.0001635602,0.00008916627,0.00004587204,0.000570611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8256336,0.05340433,0.004101967,0.0006361656,0.001279507,0.0004740715,0.0003251249,0.002525919,0.02864628,0.0004990714,0.006496603,0.07597728],"study_design_scores_gemma":[0.791958,0.1969575,0.004809177,0.00002246413,0.0002986199,0.0002877135,0.00006233191,0.0007728906,0.002323465,0.0001836216,0.002300817,0.00002338807],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912049,0.002693296,0.0004509396,0.0008699403,0.0002196095,0.001444455,0.0007537701,0.00007456341,0.002288427],"genre_scores_gemma":[0.9838145,0.003528122,0.001614219,0.001649086,0.000295911,0.001923684,0.002702927,0.00005104682,0.004420379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00411834,"threshold_uncertainty_score":0.01377726,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02548080054953892,"score_gpt":0.338689633946706,"score_spread":0.313208833397167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}